Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism

被引：0
|
作者：
Dilys Leung
Zoe K. Price
Noor A. Lokman
Wanqi Wang
Lizamarie Goonetilleke
Elif Kadife
Martin K. Oehler
Carmela Ricciardelli
George Kannourakis
Nuzhat Ahmed
机构：
[1] Ballarat Central Technology Central Park,Fiona Elsey Cancer Research Institute
[2] The University of Adelaide,Discipline of Obstetrics and Gynaecology, Adelaide Medical School, Robinson Research Institute
[3] Royal Adelaide Hospital,Department of Gynecological Oncology
[4] Federation University,School of Science, Psychology and Sport
[5] University of Melbourne,Department of Obstetrics and Gynaecology
[6] Monash University,Centre for Reproductive Health, Hudson Institute of Medical Research and Department of Translational Medicine
来源：
Journal of Translational Medicine | / 20卷
关键词：
Epithelial–mesenchymal transition; Epithelial ovarian cancer; AKR1B1; ITGAV; TGFB1; Platinum-resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer
    Nurwidya, Fariz
    Takahashi, Fumiyuki
    Murakami, Akiko
    Takahashi, Kazuhisa
    CANCER RESEARCH AND TREATMENT, 2012, 44 (03): : 151 - 156
  • [32] Epithelial-mesenchymal transition and drug resistance in breast cancer
    Huang, Jing
    Li, Hongzhong
    Ren, Guosheng
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (03) : 840 - 848
  • [33] The Role of Epithelial to Mesenchymal Transition in Colorectal Cancer Therapeutic Resistance
    Camp, E. R.
    Vaena, S. G.
    Findlay, V. J.
    Stokes, J. P.
    Hill, E. G.
    Lewin, D. N.
    Esnaola, N. F.
    Cole, D. J.
    Turner, D. P.
    Watson, D. K.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S41 - S41
  • [34] Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
    Shang, Yulong
    Cai, Xiqiang
    Fan, Daiming
    CURRENT CANCER DRUG TARGETS, 2013, 13 (09) : 915 - 929
  • [35] Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
    Arumugam, Thiruvengadam
    Ramachandran, Vijaya
    Fournier, Keith F.
    Wang, Huamin
    Marquis, Lauren
    Abbruzzese, James L.
    Gallick, Gary E.
    Logsdon, Craig D.
    McConkey, David J.
    Choi, Woonyoung
    CANCER RESEARCH, 2009, 69 (14) : 5820 - 5828
  • [36] Glycosphingolipids trigger reversible transition of mesenchymal and epithelial ovarian cancer cells
    Jacob, Francis
    Alam, Shahidul
    Liang, Ching-Yeu
    Konantz, Martina
    Huang, Yen-Lin
    Fedier, Andre
    Rimmer, Natalie
    Lopez, Monica Nunez
    Lengerke, Claudia
    Heinzelmann-Schwarz, Viola
    CLINICAL & EXPERIMENTAL METASTASIS, 2017, 34 (08) : 504 - 504
  • [37] NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer
    Qin, Shan
    Li, Yanfang
    Cao, Xuexia
    Du, Jiexian
    Huang, Xianghua
    BIOSCIENCE REPORTS, 2017, 37
  • [38] The Epithelial-Mesenchymal Transition and the Estrogen-Signaling in Ovarian Cancer
    Gallo, D.
    Ferlini, C.
    Scambia, G.
    CURRENT DRUG TARGETS, 2010, 11 (04) : 474 - 481
  • [39] The interplay between stromal density, epithelial mesenchymal transition and chemoresistance in breast cancer
    Agarwal, V.
    Spalding, L. J.
    Blick, T.
    Dobrovic, A.
    Thompson, E. W.
    Redfern, A.
    CANCER RESEARCH, 2019, 79 (04)
  • [40] COPS5 Conferred the Platinum Resistance in Epithelial Ovarian Cancer
    Zhang, Hongqin
    Yan, Tianqing
    Zhong, Ailing
    Guo, Lin
    Lu, Renquan
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (09) : 3948 - 3958
12345